Murphy & Mullick Capital Management Corp Makes New $1.52 Million Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Murphy & Mullick Capital Management Corp acquired a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 2,553 shares of the biotechnology company’s stock, valued at approximately $1,517,000. Axon Enterprise accounts for about 1.4% of Murphy & Mullick Capital Management Corp’s investment portfolio, making the stock its 14th largest position.

Other institutional investors have also made changes to their positions in the company. Public Sector Pension Investment Board boosted its holdings in Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after purchasing an additional 500 shares during the last quarter. Soros Capital Management LLC purchased a new position in shares of Axon Enterprise during the 3rd quarter valued at approximately $630,000. Friedenthal Financial grew its position in shares of Axon Enterprise by 961.7% during the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock worth $808,000 after buying an additional 1,231 shares in the last quarter. Principal Financial Group Inc. increased its stake in shares of Axon Enterprise by 33.1% in the third quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock worth $54,466,000 after buying an additional 33,869 shares during the last quarter. Finally, XTX Topco Ltd increased its stake in shares of Axon Enterprise by 20.6% in the third quarter. XTX Topco Ltd now owns 5,650 shares of the biotechnology company’s stock worth $2,258,000 after buying an additional 964 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Jeri Williams sold 307 shares of the stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares of the company’s stock, valued at $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is owned by insiders.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research report on Monday, March 10th. Finally, TD Cowen started coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus price target of $604.67.

Axon Enterprise Trading Up 0.8 %

Axon Enterprise stock opened at $577.18 on Wednesday. The firm has a 50-day moving average price of $591.92 and a two-hundred day moving average price of $546.67. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The firm has a market capitalization of $44.23 billion, a price-to-earnings ratio of 149.14, a PEG ratio of 5.17 and a beta of 1.12. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.